Thanks to all who attended our ball. 180 of us enjoyed a night of delicious food, classical music, disco dancing and good company and some glamorous attendees had photos in the local papers.
Mr Ger Loughnane, RTE broadcaster and former clare hurler and manager, is coming to University College Cork on Thursday next, January 26th, to launch the fundraising campaign to allow HERO to continue its joint research between UCC and Weill Cornell University.
Mr Loughnane will visit the research labs in Cork Cancer Research Centre before hand to see at first hand the work on leukaemia cell death mechanisms that is being carried out there.
We thanked current fundraisers at the launch and at our well attended ball in the Vienna Woods hotel.
Photo- Ger Loughnane meets students at the HERO launch recently.
Come to the HERO Launch
in the Jennings Gallery UCC at
18.00 on Thursday 26th January 2017
When people are told they have leukaemia, they often feel fear. Leukaemia is the most common cancer in children and many people have heard of it. Sometimes, people are aware of leukaemia because they know someone who has died with it. At HERO we want to change the outlook for those patients with poor prognosis leukaemia. We are continuing to research new treatment approaches so that in the decades to come that ‘fear factor’ will diminish.
In HERO we have been working closely with researchers in CancerResearch@UCC. We are actively looking at new ways to cause the leukaemia cell to ‘grow up’ and behave itself. When cancer cells cause harm to patients its often because they are immature, don’t have any useful actions, and divide rapidly. We are advancing the more novel approach of causing cells to ‘grow up’ by manipulating their cell death machinery (autophagy).
Some of our research is done in collaboration with international partners in Nottingham, Switzerland and New York. This gives us access to equipment and techniques that are not available in Ireland currently. One example of this is the rapid analysis of large amounts of DNA in cancer cells to analyse how much of it is being ‘translated’ or used to turn on cancer signals in cells. Techniques available to us through this collaboration are able to look at the DNA and its messenger (called RNA) in a single leukaemia cell.